Wilson & Boucher Capital Management’s AbbVie ABBV Stock Holding History

Wilson & Boucher Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.38M	Sell	5,490 -90	-2%	-$19.4K	0.81%	33
2026 Q1	$1.21M	Hold	5,580	–	–	0.81%	35
2025 Q4	$1.27M	Hold	5,580	–	–	0.84%	32
2025 Q3	$1.29M	Sell	5,580 -286	-5%	-$58.2K	0.85%	30
2025 Q2	$1.09M	Hold	5,866	–	–	0.76%	36
2025 Q1	$1.23M	Sell	5,866 -100	-2%	-$19.4K	0.92%	31
2024 Q4	$1.06M	Hold	5,966	–	–	0.75%	38
2024 Q3	$1.18M	Sell	5,966 -40	-0.7%	-$7.46K	0.81%	36
2024 Q2	$1.03M	Sell	6,006 -132	-2%	-$21.9K	0.79%	37
2024 Q1	$1.12M	Sell	6,138 -245	-4%	-$42.2K	0.88%	34
2023 Q4	$989K	Hold	6,383	–	–	0.83%	35
2023 Q3	$951K	Sell	6,383 -100	-2%	-$14.7K	0.9%	33
2023 Q2	$873K	Hold	6,483	–	–	0.79%	38
2023 Q1	$1.03M	Buy	6,483 +258	+4%	+$39.4K	0.99%	33
2022 Q4	$1.01M	Sell	6,225 -300	-5%	-$46K	1.03%	30
2022 Q3	$876K	Hold	6,525	–	–	1.02%	34
2022 Q2	$999K	Sell	6,525 -75	-1%	-$11.5K	1.1%	31
2022 Q1	$1.07M	Buy	6,600 +375	+6%	+$54.5K	0.97%	31
2021 Q4	$843K	Buy	+6,225	New	+$735K	0.76%	45

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wilson & Boucher Capital Management's ABBV Position: Q2 2026 in Review

Wilson & Boucher Capital Management reduced its AbbVie (ABBV) stake by 1.6% in Q2 2026, selling an estimated $19.4K and leaving 5,490 shares worth $1.38M. The position accounts for 0.81% of the portfolio, ranked #33.

Wilson & Boucher Capital Management first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 4,227 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Wilson & Boucher Capital Management held 5,490 shares of AbbVie worth $1.38M as of Q2 2026.
Wilson & Boucher Capital Management sold 90 AbbVie shares in Q2 2026, an estimated $19.4K.
AbbVie made up 0.81% of Wilson & Boucher Capital Management's portfolio in Q2 2026, its #33 holding.
Wilson & Boucher Capital Management first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
4,227 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Wilson & Boucher Capital Management's 13F filing for Q2 2026, filed 19 Aug 2026.